(AP) — Abbott Laboratories said Thursday it will develop a test intended to identify patients who might be helped by a lung cancer drug being studied by Pfizer Inc. The test is intended to scan non-small cell lung cancer tumors for a genetic mutation that exists only in those tumors and some ...
